Sidley advised CanSino Biologics Inc. (HKEX: 6185) as the Hong Kong and U.S. counsel in its HK$1.25 billion (approximately US$160.5 million) global offering and listing of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
